Literature DB >> 12923344

Sjogren's syndrome presenting as remitting seronegative symmetric synovitis with pitting edema (RS3PE).

Young Mi Choi1, Dong Hyuk Sheen, Yun Jong Lee, Eun Bong Lee, Yeong Wook Song.   

Abstract

Remitting seronegative symmetric synovitis with pitting edema (RS3PE) syndrome is characterized by symmetrical and acute synovitis, pitting edema, the absence of rheumatoid factor, increased acute phase reactants, lack of bony erosions on radiography, and benign and short clinical course. Half of all patients with Sjogren's syndrome experience arthritis during the disease course. We here describe the first case of Sjogren's syndrome presenting as RS3PE. She had swelling in knees, ankles, and wrists. After then the swelling spread to her lower legs, feet, face, and both hands. She was admitted to another hospital and was suspected of lupus or rheumatoid arthritis. Three months later, she had dry mouth and had lower lip biopsy. She was admitted to this hospital due to development of swelling in face and lower legs for 3 days. On physical examination, she had pitting edema in both hands and feet dorsum. Laboratory test showed elevated erythrocyte sedimentation rate, positivity of rheumatoid factor, anti-nuclear antibody, and anti-Ro antibody. There was no erosion in the hands radiography. Schirmer's test and lip biopsy was compatible with Sjogren's syndrome. She was diagnosed RS3PE and Sjogren's syndrome. She was begun with prednisolone and her symptoms improved gradually.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923344      PMCID: PMC3055077          DOI: 10.3346/jkms.2003.18.4.606

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  2 in total

1.  Lucky to meet RS3PE.

Authors:  Cláudia Ferrao; Raquel M Faria; Pedro Farrajota; Carlos Vasconcelos
Journal:  BMJ Case Rep       Date:  2013-10-07

2.  Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Complicated with Organizing Pneumonia.

Authors:  Chiaki Hosoda; Takashi Ishiguro; Yasuhiro Morimoto; Atsuki Furube; Taisuke Isono; Yoshihiko Shimizu; Noboru Takayanagi
Journal:  Intern Med       Date:  2020-01-17       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.